Table 2 Primary and secondary endpoints in patients with or without anticoagulation in unmatched and matched cohorts
From: Hospitalized patients with isolated distal deep vein thrombosis: anticoagulation therapy or not?
| Â | Unmatched | PSM | ||||
|---|---|---|---|---|---|---|
non-AC n = 138 | AC n = 288 | p1 | non-AC n = 111 | AC n = 111 | p2 | |
Primary endpoint | ||||||
 PDVT/ PE, n (%) | 7 (5.1) | 14 (4.9) | 0.925 | 6 (5.4) | 3 (2.7) | 0.499 |
 PDVT, n (%) | 7 (5.1) | 12 (4.2) | 0.672 | 6 (5.4) | 3 (2.7) | 0.499 |
 PE, n (%) | 1 (0.7) | 4 (1.4) | 1.000 | 1 (0.9) | 0 (0.0) | 1.000 |
 All-cause mortality, n (%) | 41 (29.7) | 47 (16.3) | 0.001 | 31 (27.9) | 21 (18.9) | 0.113 |
 Thrombosis related death, n (%) | 0 (0.0) | 0 (0.0) | - | 0 (0.0) | 0 (0.0) | - |
 Cardiovascular death, n (%) | 4 (2.9) | 8 (2.8) | 1.000 | 2 (1.8) | 3 (2.7) | 0.651 |
Secondary endpoint | ||||||
 Thrombosis resolution, n (%) | 58 (42.0) | 155 (53.8) | 0.023 | 48 (43.2) | 57 (51.4) | 0.226 |
 Bleeding, n (%) | 9 (6.5) | 8 (2.8) | 0.065 | 6 (5.4) | 5 (4.5) | 0.757 |